WeVote

Bill

Bill

S 854

Risky Research Review Act

119th Congress Introduced by Rand Paul and 1 co-sponsor

The bill creates a formal risk review process for federally funded research with potential public health, safety, or national security risks before funding approval.

Committee on Homeland Security and Governmental Affairs. Reported by Senator Paul without amendment. Without written report.
0
WeVote Research Nonpartisan
Bill Summary · S 854

Legislative bill overview

The Risky Research Review Act (S 854) aims to enhance oversight of federally funded research projects that present heightened risks to public health, safety, or national security. The bill proposes establishing a formal review process to identify, assess, and mitigate potential risks associated with certain types of research before funding approval. This includes creating specific criteria for risk evaluation and involving relevant federal agencies to ensure proper regulation and accountability.

Why is this important

This bill addresses growing concerns about scientific research that could have unintended negative consequences, such as dual-use research with potential for misuse or research involving hazardous biological agents. By implementing structured risk reviews, the legislation seeks to prevent dangerous outcomes that could harm public safety or national interests while ensuring responsible scientific progress. It promotes transparency and accountability in federally funded research.

Potential points of contention

  • The bill could potentially slow down scientific innovation due to added bureaucratic layers and extended review timelines.
  • There may be disagreements over what qualifies as research, leading to inconsistent application or over-caution.
  • Increased government oversight might be perceived as infringing on academic freedom and autonomy in research.
  • The cost and resource allocation for implementing these reviews could be significant, potentially diverting funds from actual research.
  • Balancing national security concerns with open scientific collaboration could be challenging, possibly limiting beneficial international partnerships.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.